Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Primary biliary cirrhosis

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Digestive system
Digestive system
Bile pathway
Bile pathway

Alternative Names    Return to top

PBC

Definition    Return to top

Primary biliary cirrhosis is an inflammation (irritation and swelling) of the bile ducts of the liver resulting in narrowing and obstruction of the flow of bile. This obstruction damages liver cells.

Causes    Return to top

The cause of inflamed bile ducts within the liver in this condition is not known. The disease more commonly affects middle-aged women. The onset of symptoms is gradual, with fatigue and itching skin as the most common first symptom.

Long-standing bile obstruction is believed to lead to liver cirrhosis. The disease may be associated with autoimmune disorders such as hypothyroidism, Raynaud's, CREST syndrome, and arthritides. There are about 3 to 15 cases per million people in the U.S. population each year.

Symptoms    Return to top

Exams and Tests    Return to top

Tests that suggest or confirm the disease:

Tests that reveal liver dysfunction:

Treatment    Return to top

Therapy is aimed at relief of symptoms and prevention of complications.

Cholestyramine (or colestipol) may reduce the itching by reducing blood levels of bile acids and increasing removal of bile acids in the skin. Ursodeoxycholic acid may also improve removal of bile from the bloodstream.

Vitamin replacement therapy restores fat-soluble vitamins A, K, and D lost in fatty stools. A calcium supplement is indicated to prevent osteomalacia.

Periodic evaluation and drainage with ERCP  (endoscopic retrograde cholangiopancreatography) or PTC (percutaneous transhepatic cholangiography) may be necessary.

Treatment for episodes of cholangitis may be necessary.

Liver transplant for primary biliary cirrhosis prior to liver failure has been successful.

Outlook (Prognosis)    Return to top

The course is variable, but if the condition is untreated, most patients will need a liver transplant after about seven years. Statistical models are now used to predict the best timing for transplantation.

Possible Complications    Return to top

Progressive cirrhosis can lead to liver failure -- including bleeding, malnutrition, renal failure, fluid, and electrolyte imbalance -- and encephalopathy (damage to the brain). Osteodystrophy (a condition that softens the bones) and malabsorption may develop.

When to Contact a Medical Professional    Return to top

Call your health care provider if prolonged itching of the skin develops that is not related to other causes, or if jaundice or other symptoms of cirrhosis develop.

Vomiting blood, blood in the stools, confusion, abdominal swelling, and jaundice are symptoms that indicate cirrhosis may be worsening. Call your provider if these or other new symptoms develop.

Update Date: 5/4/2006

Updated by: Jenifer K. Lehrer, MD, Department of Gastroenterology, Frankford-Torresdale Hospital, Jefferson Health System, Philadelphia, PA. Review provided by VeriMed Healthcare Network.

A.D.A.M. Logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2008, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.